BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 10384918)

  • 1. Serum levels of soluble TNF alpha receptor type I and the severity of systemic sclerosis.
    Majewski S; Wojas-Pelc A; Malejczyk M; Szymanska E; Jablonska S
    Acta Derm Venereol; 1999 May; 79(3):207-10. PubMed ID: 10384918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis.
    Lee YJ; Shin KC; Kang SW; Lee EB; Kim HA; Song YW
    Clin Exp Rheumatol; 2001; 19(1):69-74. PubMed ID: 11247328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Soluble receptors of cytokines in sera of patients with systemic sclerosis--clinical correlation].
    Lis AD; Brzezińska-Wcisło LA
    Wiad Lek; 2003; 56(11-12):532-6. PubMed ID: 15058159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble intercellular adhesion molecule-1 (sICAM-1) and soluble interleukin-2 receptors (sIL-2R) in scleroderma skin.
    Søndergaard K; Stengaard-Pedersen K; Zachariae H; Heickendorff L; Deleuran M; Deleuran B
    Br J Rheumatol; 1998 Mar; 37(3):304-10. PubMed ID: 9566672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble TNF and IL-2 receptors in patients with breast cancer.
    Tesarová P; Kvasnicka J; Umlaufová A; Homolková H; Jirsa M; Tesar V
    Med Sci Monit; 2000; 6(4):661-7. PubMed ID: 11208388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum levels of soluble tumor necrosis factor receptors (sTNF-Rs) in children and adolescents with vertically and horizontally transmitted HIV infection.
    Weiss M; Martignoni M; Petropoulou T; Sölder B; Belohradsky BH
    Infection; 1996; 24(4):301-8. PubMed ID: 8875282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble adhesion molecules and cytokines in patients with myasthenia gravis treated by plasma exchange.
    Tesar V; Jelínková E; Jirsa M; Bakosová M; Pitha P; Chábová V
    Blood Purif; 2000; 18(2):115-20. PubMed ID: 10838470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What biochemical markers are best for measuring the extent of disease in patients with sclerosis?
    Thestrup-Pedersen K
    Acta Derm Venereol; 1999 May; 79(3):177. PubMed ID: 10384910
    [No Abstract]   [Full Text] [Related]  

  • 9. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T; Gladalska A; Stepień H
    Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure.
    Nozaki N; Yamaguchi S; Shirakabe M; Nakamura H; Tomoike H
    Jpn Circ J; 1997 Aug; 61(8):657-64. PubMed ID: 9276770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble TNF-alpha receptor and IL-1 receptor antagonist elevation in BAL in active pulmonary TB.
    Tsao TC; Li L; Hsieh M; Liao S; Chang KS
    Eur Respir J; 1999 Sep; 14(3):490-5. PubMed ID: 10543265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Soluble adhesive molecules and cytokines in patients with myasthenia gravis treated with plasmapheresis].
    Tesar V; Jelínková E; Jirsa M; Bakosová N; Pit'ha V; Chábová V
    Cas Lek Cesk; 1998 Nov; 137(21):654-9. PubMed ID: 9929930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum leptin concentrations correlate with soluble tumour necrosis factor receptor levels in patients with cirrhosis.
    Lin SY; Wang YY; Sheu WH
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):805-11. PubMed ID: 12460331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactivity of prolactin in systemic sclerosis.
    La Montagna G; Meli R; Criscuolo T; D'Angelo S; Valentini G
    Clin Exp Rheumatol; 2004; 22(2):145-50. PubMed ID: 15083880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of circulating intercellular adhesion molecule-1 in patients with systemic sclerosis.
    Kiener H; Graninger W; Machold K; Aringer M; Graninger WB
    Clin Exp Rheumatol; 1994; 12(5):483-7. PubMed ID: 7842528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble cytokine receptors and the low 3,5,3'-triiodothyronine syndrome in patients with nonthyroidal disease.
    Boelen A; Platvoet-Ter Schiphorst MC; Wiersinga WM
    J Clin Endocrinol Metab; 1995 Mar; 80(3):971-6. PubMed ID: 7883859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of serum eosinophil cationic protein, soluble tumor necrosis factor receptors and soluble intercellular adhesion molecule-1 levels in acute bronchial asthma.
    Kokuludağ A; Sin A; Terzioğlu E; Saydam G; Sebik F
    J Investig Allergol Clin Immunol; 2002; 12(3):211-4. PubMed ID: 12530121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor necrosis factor receptors sTNF-RI and sTNF-RII in advanced chronic heart failure].
    Nowak J; Rozentryt P; Szewczyk M; Gierlotka M; Duszańska A; Szyguła B; Wojnicz R; Hawranek M; Poloński L; Zembala M
    Pol Arch Med Wewn; 2002 Mar; 107(3):223-9. PubMed ID: 12107980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum aminoterminal propeptide of type III procollagen in progressive systemic sclerosis and localized scleroderma.
    Zachariae H; Halkier-Sørensen L; Heickendorff L
    Acta Derm Venereol; 1989; 69(1):66-70. PubMed ID: 2563612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependent levels of select immunological mediators in sera of healthy children.
    Sack U; Burkhardt U; Borte M; Schädlich H; Berg K; Emmrich F
    Clin Diagn Lab Immunol; 1998 Jan; 5(1):28-32. PubMed ID: 9455875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.